Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Medicinova (MNOV) EBIT Margin (2021 - 2025)

Medicinova (MNOV) has disclosed EBIT Margin for 6 consecutive years, with 2498.62% as the latest value for Q4 2025.

  • Quarterly EBIT Margin changed N/A to 2498.62% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 3413.1% through Dec 2025, changed N/A year-over-year, with the annual reading at 3242.47% for FY2025, N/A changed from the prior year.
  • EBIT Margin for Q4 2025 was 2498.62% at Medicinova, up from 2741.67% in the prior quarter.
  • The five-year high for EBIT Margin was 5.04% in Q1 2021, with the low at 9605.17% in Q3 2021.
  • Average EBIT Margin over 3 years is 2940.84%, with a median of 2589.25% recorded in 2025.